openPR Logo
Press release

Japan Industry Statistics of Uveitis Treatment

07-12-2021 07:41 AM CET | Health & Medicine

Press release from: Transparency Market Research

Global Uveitis Treatment Market: Overview

Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.

Read Report Overview:

As per Cochrane, an international non-profit organization based in the U.K., uveitis is the fifth most common cause for loss of vision in advanced countries. It accounts for 5% to 20% of blindness, mostly in working-age people. In developed and underdeveloped countries, uveitis accounts for 2.4% to 24% of legal blindness.

The report on the global uveitis treatment market has been prepared after a meticulous study of the market, including its revenue and growth prospects. It presents valuable market insights through the use of analytical tools such as Porter’s Five Forces, which factors in supplier power, buyer power, competitive rivalry, threat of substitution, and threat of new entrants to uncover opportunities for new and existing players. The report also classifies the different types of uveitis and segments the market based on the medications available into corticosteroids, glucocorticoid steroids, ophthalmic steroids with anti-infectives, and antirheumatics. An in-depth picture of the market for each is presented.

Request Brochure of Report -

Global Uveitis Market: Trends and Opportunities

The prime driver in the market is the rising incidence of uveitis and the complications related to it. Besides, rising expenditure on the research and development of new drugs and treatments and the introduction of innovative biologics is fueling market growth. In fact, new treatment options for uveitis such as corticosteroids and anti-inflammatory drugs are already gaining traction in the market. Further, speedy approvals of drugs in the pipeline and new routes of drug administration that improves the efficacy of the drug are other factors providing fillip to the market.

While drivers are many for the market, there are a few restraints that might hamper the growth. Some of them are the steep prices of medications and side effects of the medication, such as watery eyes and irritation. In developing and underdeveloped nations, the lack of knowledge about eye disorders, shoddy primary healthcare infrastructure, and the lack of health insurance are also said to be hindering the market.

Based on the type of uveitis, the anterior uveitis market has outpaced others, with a more-than-healthy CAGR. Anterior uveitis involves the inflammation of the middle layer of the eye, which includes the iris and ciliary body. They can be acute or chronic in nature, and are caused mainly due to auto-immune disorders and bacterial, fungal, or viral infections.

Request for Custom Research -

Global Uveitis Treatment Market: Region-wise Outlook:

North America has been the market leader in uveitis treatment, due to the early approval of pipeline drugs as compared to other regions. Other factors resulting in the growth of the regional market are the rising incidence of uveitis and related disorders, growing geriatric population, and increasing investments in research and development by drug manufacturing companies for innovating new treatments such as corticosteroids.

In Europe, the uveitis treatment market has been boosted by the growing occurrence of autoimmune disorders, namely AIDS and multiple sclerosis. Germany, in particular, has seen rapid growth on account of a growing number of elderly and the high incidence of eye disorders. The market in Asia is also expanding fast for the same reasons the markets in North America and Europe are expanding.

Pre Book Uveitis Treatment Market Report at<ype=S

Companies Mentioned in the Research Report:

Some of the top players operating within the global uveitis treatment market currently include Bausch & Lomb Inc., AbbVie Inc., Eyegate Pharmaceuticals Inc., Alimera Sciences Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd.

More Trending Reports by Transparency Market Research –

Ophthalmic Ultrasound Systems Market:

Corneal Topographers Market:


Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453


About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japan Industry Statistics of Uveitis Treatment here

News-ID: 2325928 • Views:

More Releases from Transparency Market Research

Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiting a CAGR of 5.5% | States Transparency Market Research, Inc
Photochromic Lenses Market Size & Share to Surpass USD 10.9 Bn by 2031, Exhibiti …
Photochromic lenses, known for their ability to adjust to varying light conditions, are gaining significant traction in the eyewear industry. These adaptive lenses darken on exposure to sunlight and clear up indoors, providing convenience and protection. Available in various materials and incorporating advanced technologies, photochromic lenses cater to diverse consumer needs, enhancing their appeal and functionality. In 2022, the global photochromic lenses market was valued at an impressive US$ 6.8 billion.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR of 5.8%- Transparency Market Research, Inc.
Hysteroscopes Market Projected to Reach USD 446.6 Mn by 2031, Growing at a CAGR …
The hysteroscopes market is poised for significant growth over the next decade, driven by advancements in medical technology and increasing demand for minimally invasive procedures. These specialized medical devices are crucial in the examination and treatment of the uterine cavity, providing both diagnostic and therapeutic benefits. As healthcare technology evolves, hysteroscopes are becoming more sophisticated, offering enhanced precision and patient comfort. This article delves into the projected growth, key drivers,
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6.1% | Exclusive Report by Transparency Market Research, Inc.
Respiratory Devices Market Size/Share Worth USD 37.7 Bn by 2031, at a CAGR of 6. …
The global respiratory devices market is on the brink of substantial growth, driven by a convergence of technological advancements, an increasing prevalence of respiratory diseases, and demographic shifts such as an aging population. From therapeutic devices like ventilators and inhalers to diagnostic and monitoring tools such as spirometers and pulse oximeters, the respiratory devices market is poised to see a significant upsurge in demand over the coming decade. This detailed
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency Market Research, Inc.
Sharps Containers Market Worth USD 1.0 Bn, at a 4.7% CAGR By 2031 - Transparency …
In the realm of healthcare, the safe disposal of sharps-needles, syringes, and other sharp medical instruments-is not just a regulatory requirement but a crucial element of infection control and workplace safety. The global sharps containers market, valued at US$ 701.1 million in 2022, is set to expand significantly, projected to reach US$ 1.0 billion by 2031 with a steady compound annual growth rate (CAGR) of 4.7%. This growth trajectory underscores

All 5 Releases

More Releases for Uveitis

Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &
Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and
Global Uveitis Treatment Market Industry Analysis and Forecast
Market Research Reports Search Engine (MRRSE) has included a new study titled, “Global Market Study on Uveitis Treatment-Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”.Persistence Market Research presents a comprehensive study of the global uveitis treatment market in a new publication titled “Uveitis Treatment Market: Global Industry Analysis and Forecast, 2016–2024.” The report forecasts the performance of the global uveitis treatment market across different geographical locations and critically